Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.48 |
| ▸ | LIPC | P11150 | 2/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.46 |
| ▸ | RXRA | P19793 | 6/20 | 0.45 |
| ▸ | NR1H2 | P55055 | 6/20 | 0.45 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.45 |
| ▸ | CFTR | P13569 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.44 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.43 |
| ▸ | PLK1 | P53350 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24908522 | 0.83 | ALDH1A1 (0.54) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| SCHEMBL8477461 | 0.80 | ALDH1A1 (0.54) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| SCHEMBL8477458 | 0.80 | ALDH1A1 (0.54) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| SCHEMBL6756787 | 0.79 | KEAP1 (0.49) | KDM4EALDH1A1MRGPRX4CES2 | |
| SCHEMBL6993058 | 0.79 | ALDH1A1 (0.57) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| SCHEMBL2337724 | 0.79 | ALDH1A1 (0.53) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| Ammonia Solution, Strong SCHEMBL7105697 | 0.78 | ALDH1A1 (0.49) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| SCHEMBL3930119 | 0.78 | CYP3A4 (0.54) | KDM4EALDH1A1HPGDHSD17B10USP2 | |
| SCHEMBL27856831 | 0.77 | SRD5A2 (0.53) | MRGPRX4RXRANR1H2NR1H3 | |
| SCHEMBL27541096 | 0.77 | LMNA (0.50) | KDM4EALDH1A1MRGPRX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2851366-A1 | Compounds as cannabinoid receptor ligands | Abbvie Inc. (US) | 2015-03-25 | — | — | EP | disclosed |
| US-8492371-B2 | Compounds as cannabinoid receptor ligands | ABBVIE INC. (US) | 2013-07-23 | — | — | US | disclosed |
| CN-102448957-A | Compounds as cannabinoid receptor ligands | ABBOTT LAB | 2012-05-09 | — | — | CN | disclosed |
| EP-2411382-A1 | COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | disclosed |
| US-20100249129-A1 | COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | US | disclosed |
| WO-2010111572-A1 | COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249129-A1 | COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | CNR1, CNR2, GPR18 | KDM4E 1939/4885ALDH1A1 660/4885HPGD 1294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.